October 10th, Gleonhui | nt pharma (1011.HK) surged 250%, the company announced its consideration of issuing a certain amount of new shares to four creditors (subscribers), including two major shareholders of the company, in order to capitalize the outstanding principal and interest on the existing loans owed to the subscribers of the group.
港股泰凌医药大幅高开250%
Hong Kong stock nt pharma opened significantly higher by 250%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated